Literature DB >> 9880050

Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging.

M Y Su1, E Head, W M Brooks, Z Wang, B A Muggenburg, G E Adam, R Sutherland, C W Cotman, O Nalcioglu.   

Abstract

Dogs exhibit both neuroanatomical and cognitive changes as a function of age that parallel those seen in aging humans. This study describes in vivo changes in neuroanatomical and cerebrovascular characteristics of the canine brain as a function of age in a group of dogs ranging from 4 to 15 years old. Dynamic contrast-enhanced magnetic resonance imaging (MRI) was used to measure the kinetics of contrast agents in the brain. Measures of vascular volume and blood-brain barrier (BBB) permeability were derived from a pharmacokinetic analysis. Cortical atrophy and ventricular enlargement were characteristic features of the aged canine brain. Vascular volume did not vary as a function of age and BBB permeability exhibited a nonsignificant increasing trend with age. However, BBB dysfunction was detected in one middle-aged dog that in addition to having unusually large ventricles, demonstrated an early onset of diffuse senile plaques at postmortem. These findings indicate that BBB dysfunction detected by magnetic resonance imaging may be useful for predicting and potentially diagnosing early pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9880050     DOI: 10.1016/s0197-4580(98)00081-5

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  35 in total

1.  Rhinal and dorsolateral prefrontal cortex lesions produce selective impairments in object and spatial learning and memory in canines.

Authors:  Lori-Ann Christie; Richard C Saunders; Danuta M Kowalska; William A MacKay; Elizabeth Head; Carl W Cotman
Journal:  J Comp Neurol       Date:  2008-11-10       Impact factor: 3.215

2.  Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging.

Authors:  J M Starr; J Wardlaw; K Ferguson; A MacLullich; I J Deary; I Marshall
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

3.  Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.

Authors:  Wycliffe O Opii; Gururaj Joshi; Elizabeth Head; N William Milgram; Bruce A Muggenburg; Jon B Klein; William M Pierce; Carl W Cotman; D Allan Butterfield
Journal:  Neurobiol Aging       Date:  2006-10-20       Impact factor: 4.673

4.  Immunoreactivities and levels of mineralocorticoid and glucocorticoid receptors in the hippocampal CA1 region and dentate gyrus of adult and aged dogs.

Authors:  Jung Hoon Choi; In Koo Hwang; Choong Hyun Lee; Dae Won Chung; Ki-Yeon Yoo; Hua Li; Moo-Ho Won; Je Kyung Seong; Yeo Sung Yoon; In Se Lee
Journal:  Neurochem Res       Date:  2007-11-06       Impact factor: 3.996

Review 5.  A canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2013-03-23

6.  Lafora disease as a cause of visually exacerbated myoclonic attacks in a dog.

Authors:  Aubrey A Webb; Chantal McMillan; Cheryl L Cullen; Sarah E Boston; Julie Turnbull; Berge A Minassian
Journal:  Can Vet J       Date:  2009-09       Impact factor: 1.008

7.  Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines.

Authors:  Lori-Ann Christie; Wycliffe O Opii; Elizabeth Head
Journal:  Age (Dordr)       Date:  2008-06-22

8.  Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.

Authors:  Joseph A Araujo; Christa M Studzinski; Elizabeth Head; Carl W Cotman; Norton W Milgram
Journal:  Age (Dordr)       Date:  2005-05-02

Review 9.  Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain aging.

Authors:  Elizabeth Head
Journal:  Neurochem Res       Date:  2008-08-06       Impact factor: 3.996

Review 10.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.